|Day Low/High||134.85 / 137.22|
|52 Wk Low/High||78.29 / 136.30|
I am simply respectful of the power of hope melded with the strength of so many parts of technology and I want to buy, not sell, these stocks when they get hammered.
While chip stocks are now pricing in a lot of optimism, the latest headlines aren't exactly giving bulls cold feet.
During a talk with TheStreet, NXP CTO Lars Reger went into detail about his firm's R&D strategy for various growth markets.
This is a market that thrives on certainty. We got it Friday.
Beijing is intent on reducing its dependence on American hardware, software and chips. But reducing it and eliminating are two very different things.
There's still some value to be found in the sector. But a lot of the easy money has definitely been made.
We're seeing lots of companies snapping up their peers, and the market is applauding.
Qualcomm's shares moved lower after it forecast strong growth for a chip business that will benefit from 5G adoption, but offered a more measured growth outlook for its patent-licensing business.
Though major chip suppliers shared both good and bad news in October, on the whole the positives outweighed the negatives.
iPhone sales and pricing trends, Chinese demand and wearables and services growth are among the things to watch as Apple reports.
The odds of a Fed December rate cut are now very low. I think the marketplace handles that just fine, as long as the statement with this week's expected cut does not sound too tough, or too cautious.
Rest up for a busy week that includes earnings from Apple, Facebook and Starbucks.
Despite playing the industry and macro blame game on the conference call, TXN execs may have overstated the significance of those factors in the company's poor report and outlook.
STMicroelectronics and Sony each appear to be supplying four chips for Apple's latest flagship iPhones. Many other historical iPhone suppliers also make appearances in the latest teardowns.
So many companies -- like Netflix, Facebook and Johnson & Johnson -- are not trading on earnings per share, but on factors that are nearly impossible to quantify.
The bond market is running the show? The answer would be... as much if not more than anything else... again.
Possibly due to worries about the fixed costs attached to their business models, many fab-owning chip suppliers with meaningful growth opportunities are still trading at low valuations.
NXP and many other chip stocks still trade at reasonable valuations. But the group's margin of safety has diminished some following recent gains, and industry news remains pretty mixed.
After the market close, we have a number of earnings reports coming at us, and one of my standard practices is to make a list as to which companies are reporting, and what's expected. This way, as the results hit the tape, I can perform a quick tria...
The real threat here would be if the Fed were fooled by domestic economic data that remains better than bad, from properly preparing for a very uncertain future.
There still appears to be plenty of interest among chip developers in further consolidation, and the easing of export restrictions on Huawei might make them less worried about Chinese regulators.
As chip stocks gain nearly across the board following numbers from Micron that weren't exactly stellar, it's worth remembering how low valuations for many names had gotten.
Broadcom's Huawei mess is at the heart of Trump's disregard for what happens to American businesses.
The tech giant's reported effort to create a wearable that can detect human emotions shows how it's hardware efforts are swelling, and also its willingness to bet on projects that are far from guaranteed to succeed.
Given the sidestepping of trade restrictions for the European chipmakers, they could be poised to fill the void left by larger U.S. competitors that have long been dominant in the region.
Nvidia still needs China's approval for the buyout of Mellanox.
Trade worries have by themselves affected the Chinese sales of many tech companies.
Nvidia's biggest acquisition is in the hands of Chinese regulators at an inopportune time.